Hemostemix Inc. (CVE:HEM – Get Free Report)’s share price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$0.08 and traded as high as C$0.10. Hemostemix shares last traded at C$0.10, with a volume of 85,000 shares changing hands.
Hemostemix Trading Up 26.7 %
The company has a fifty day moving average price of C$0.08 and a two-hundred day moving average price of C$0.07. The firm has a market capitalization of C$8.28 million, a PE ratio of -4.75 and a beta of 0.20.
About Hemostemix
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.
Recommended Stories
- Five stocks we like better than Hemostemix
- Where to Find Earnings Call Transcripts
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What to Know About Investing in Penny Stocks
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Industrial Products Stocks Investing
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
